Cytotoxic effects of ellagitannins isolated from walnuts in human cancer cells

Area of Science:

• Nutritional biochemistry
• Cancer biology
• Cellular mechanisms

Background:

• Walnuts possess bioactive compounds with potential anticancer properties.
• Previous studies indicated walnut diets reduce tumor size in mice.
• The precise anticancer mechanisms of walnuts remained undetermined.

Purpose of the Study:

• To investigate the anticancer effects of a walnut methanol extract on human cancer cell lines.
• To identify specific compounds responsible for the observed cytotoxicity.
• To elucidate the cellular mechanisms underlying walnut-induced cancer cell death.

Main Methods:

• Preparation and application of a methanol extract from walnuts.
• Cytotoxicity assays on MDA-MB-231, MCF7, and HeLa human cancer cells.
• Identification of bioactive compounds using chemical analysis.
• Assessment of cellular effects including intracellular pH, mitochondrial membrane potential, cytochrome c release, and mitochondrial respiration.

Main Results:

• The walnut extract exhibited cytotoxicity against all tested cancer cell lines.
• Tellimagrandin I and Tellimagrandin II were identified as major cytotoxic compounds.
• Extract treatment led to decreased intracellular pH and mitochondrial membrane depolarization.
• Cytochrome c release, phosphatidylserine flipping, and reduced mitochondrial respiration were observed.

Conclusions:

• Walnut extract induces apoptosis and impairs mitochondrial function in cancer cells.
• Ellagitannins, specifically Tellimagrandin I and II, are key mediators of these effects.
• These findings suggest a mechanism for the anticancer potential of walnuts.